Navigation Links
Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
Date:9/24/2007

Barcelona, Spain: A way of predicting which patients will respond well to treatment with a common chemotherapy drug used in breast cancer was unveiled at the European Cancer Conference (ECCO 14) today (Monday 24 September). Dr Iain Brown, from the University of Aberdeen, Aberdeen, Scotland, told the conference that he and his colleague, Dr Andrew Schofield, had identified two genes that could identify which cells would be resistant and which would respond to docetaxel.

Docetaxel is one of the most effective chemotherapy treatments in advanced breast cancer. It works by binding to cell components called microtubules, and stabilising them so that they do not disassemble. They then accumulate within the cell and bring about apoptosis, or cell death. However, up to half of all patients treated with this drug will develop resistance, and hence the treatment will fail, said Dr Brown.

The scientists decided to look for a specific genetic make-up in patients where docetaxel treatment had failed, in the hope that this might explain why they became resistant to the drug. They used micro-array analysis, a technique that allowed them to look at every known gene in our cells at once, to identify genes that were significantly associated with such resistance.

By going back to the laboratory, using breast cancer cell lines, we can eliminate much of the variation in gene expression found in different patients, and thus remove a lot of background noise, said Dr Brown. We developed a unique model of docetaxel resistance in breast cancer from two different cell lines made resistant to the drug by exposing them to increasing concentrations of the drug. This model has also allowed us to test cells which are resistant to low levels of the drug and cells which are resistant to high levels.

Drs Brown and Schofield now intend to carry the research further, by applying their findings to patient samples to see whether the gene set they have discovered h
'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
Federation of European Cancer Societies
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Molecular markers for early diagnosis of breast and ovarian cancer
2. Scientists Developed Map For Brain Molecular Communities
3. Molecular Mechanism Of HIV Infecting The Healthy Cells Discovered.
4. Molecular Flaw Detected in Aggressive Breast Cancers
5. Molecular Computer Developed To perform Calculations From Within Human Body
6. Lung cancer molecular profile discovered by researchers.
7. Molecular Imaging Of Cancer Now Possible, New Hybrid Virus Produced
8. Molecular Basis Of ALS Found
9. New Molecular Treatment Identified To Treat Blood Cell Cancers
10. Researchers Find Molecular "Brake" to Cell Death
11. Solitons Could Power Molecular Electronics, Artificial Muscles

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ewswire/--TheBayAreaAirQualityManagementDistrictis...Air Alert forThursday,November26,2009whichban...el,bothindoorsandoutdoors. ,, "Cold,stillweathe...JackBroadbent,executiveofficeroftheAirDistrict."We...neighborsandfellowcommunitymembersthisThanksgiving...
(Date:11/25/2009)...ce of a statistically significant survival benefit...ogen receptor (ER)-positive tumors had high levels...-alpha S118-P), according to a brief communication...he National Cancer Institute . , Approximately 5.... Preclinical studies have shown that ER-alpha S11...
(Date:11/25/2009)...too short to draw definite conclusions, experts sa...ws) -- In diabetic patients with blocked coronary ...comes at one year whether patients undergo bypass ...archers report. , Bypass surgery has been the s...ary artery disease. However, less invasive approac...
(Date:11/25/2009)...ad mothers to overlook needed care, study finds ,... A mother,s depression can worsen her child,s asth...nth study of 262 black mothers and their children ...ive symptoms had more frequent asthma symptoms, wh...toms had less frequent asthma symptoms. , The J...
(Date:11/25/2009)...re/-- MISSIONSkincare ®isproudtosupportGNC,se...NC,sannualSt.Jude ThanksandGiving campaign,$1fromt...ER-C(TM)LipBalm willbedonatedtoSt.Jude.Additionall...onationatcheckoutatoneoftheir5,000+retaillocations...Judeduringtheir2009 ThanksandGiving campaign. ,...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Mom's Depression May Worsen Child's Asthma 2Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2
...ay soon be possible to take a simple blood test an... a particular molecule, predisposing them to the d...tive, it may then be possible to use preventative ...earch who have shown conclusively that people who ...
... EPS from Continuing Operations up 72% over 2006, ...asdaq: AFAM ) today announced its operating resul...7 with record performance reported for both,period... December 31, 2007 as compared to $1,412,988 o...
... Dollar Body(TM) Is Awarding Over One Million Doll...d Get in Better Shape, ANAHEIM, Calif., March 10 ...nounced a $50,000 Grand Prize winner in,its Millio..., In a little over a year, Longview Washington,s ...
... Dollar Body(TM) Is Awarding Over One Million Doll...d Get in Better Shape, ANAHEIM, Calif., March 10 ...nounced a $50,000 Grand Prize winner in,its Millio... Melanie Ristau of Freeland, Michigan appeared tod...
... Dollar Body(TM) Is Awarding Over One Million Doll...d Get in Better Shape, ANAHEIM, Calif., March 10 ...nounced a $50,000 Grand Prize winner in,its Millio... Scott Shoup from Columbus, Ohio appeared today in...
...widely used synthetic progestin medroxyprogesteron...premenopausal women in a study done at the Univers...es concerns about long-term effects of MPA and pos...as been found to be a dynamic organ that serves an...
Other Medicine News:Health News:Low levels of PYY hormone a very early indicator of type 2 diabetes 2Health News:Almost Family Announces Record Quarterly and Year End Results 2Health News:Almost Family Announces Record Quarterly and Year End Results 3Health News:Almost Family Announces Record Quarterly and Year End Results 4Health News:Almost Family Announces Record Quarterly and Year End Results 5Health News:Almost Family Announces Record Quarterly and Year End Results 6Health News:Almost Family Announces Record Quarterly and Year End Results 7Health News:Almost Family Announces Record Quarterly and Year End Results 8Health News:Almost Family Announces Record Quarterly and Year End Results 9Health News:Almost Family Announces Record Quarterly and Year End Results 10Health News:Almost Family Announces Record Quarterly and Year End Results 11Health News:Longview, WA Man Wins $50,000 for Losing 82 Pounds 2Health News:Longview, WA Man Wins $50,000 for Losing 82 Pounds 3Health News:Freeland, MI Woman Wins $50,000 for Losing Weight, Adding Muscle and Changing Her Life 2Health News:Freeland, MI Woman Wins $50,000 for Losing Weight, Adding Muscle and Changing Her Life 3Health News:Columbus, OH Man Wins $50,000 for Losing 71 Pounds 2Health News:Columbus, OH Man Wins $50,000 for Losing 71 Pounds 3Health News:Oregon study raises questions on synthetic progestins 2Health News:Oregon study raises questions on synthetic progestins 3
(Date:11/25/2009)...re/--Reportlinker.comannouncesthatanewmarketresear...atesDentalDevicesMarketAnalysisandForecaststo2015 ...d-States-Dental-Devices-Market-Analysis-and-Foreca...arketAnalysisandForecaststo2015 ,, Summary ,...ationanddatarelatingtotheUSdentaldevicesmarket.Ita...
(Date:11/25/2009)...25/PRNewswire/--SwissrayInternational,Inc.aleading...ms,announcedtodaythatitsoperationshavebeenacquired...wingSwissray,smedicalimagingbrand.Theacquisitionin...tractsandinventory.After25yearsofsuccessandgrowthS...caladvancementswithstableandsteadygrowth. ,, "S...
(Date:11/25/2009)...PRNewswire/--CempraPharmaceuticalsInc.todayannounc...iveofficer,willpresentatthePiperJaffray21stAnnualH...TheNewYorkPalaceHotelinNewYorkCity.Dr.Fernandeswil...icclinicalprogramsforthetreatmentofdrug-resistantp...ticals ,, Foundedin2006,CempraPharmaceuticalsi...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Swissray International Announces New Ownership 2Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009 48136 1Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009 48136 2Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009 48136 3Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009 48136 4Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009 48136 5Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009 48136 6Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009 48136 7EarlySenses EverOn 28TM 29 System Receives FDA Clearance and CE Mark Certification 12504 1EarlySenses EverOn 28TM 29 System Receives FDA Clearance and CE Mark Certification 12504 2Merz Pharmaceuticals Announces Results of Clinical Trials with NT 201 28Botulinum neurotoxin type A free from complexing proteins 29 at Annual Movemen 4556 1Merz Pharmaceuticals Announces Results of Clinical Trials with NT 201 28Botulinum neurotoxin type A free from complexing proteins 29 at Annual Movemen 4556 2Merz Pharmaceuticals Announces Results of Clinical Trials with NT 201 28Botulinum neurotoxin type A free from complexing proteins 29 at Annual Movemen 4556 3Merz Pharmaceuticals Announces Results of Clinical Trials with NT 201 28Botulinum neurotoxin type A free from complexing proteins 29 at Annual Movemen 4556 4
8500 series Digital Handheld Pulse Oximeter
Digit Finger Pulse Oximeter
Onyx® 9500
Printing Pulse Oximeter
Medicine Products: